Literature DB >> 20422267

Potential aggregation-prone regions in complementarity-determining regions of antibodies and their contribution towards antigen recognition: a computational analysis.

Xiaoling Wang1, Satish K Singh, Sandeep Kumar.   

Abstract

PURPOSE: To analyze contribution of short aggregation-prone regions (APRs), which may self-associate via cross-beta motif and were earlier identified in therapeutic mAbs, towards antigen recognition via structural analyses of antibody-antigen complexes.
METHODS: A dataset of 29 publically available high-resolution crystal structures of Fab-antigen complexes was collected. Contribution of APRs towards the surface areas of the Fabs buried by the cognate antigens was computed. Propensities of amino acids to occur in APRs and to be involved in antigen binding were compared. Coincidence between APRs and individual CDR loops was examined.
RESULTS: All Fabs in the dataset contain at least one APR in CDR loops and adjacent framework beta-strands. The average contribution of APRs towards buried surface area of Fabs is 16.0 +/- 10.7%. Aggregation and antigen recognition may be coupled via aromatic residues (Tyr, Trp), which occur with high propensities in both APRs and antigen binding sites. APRs are infrequent in the heavy chain CDR 3 (H3) loops (7%), but are frequent in H2 loops (45%).
CONCLUSIONS: Co-incidence of APRs with antigen recognition sites can potentially lead to the loss of function upon aggregation. Rational structure-based design or selection strategies are suggested for biotherapeutics with improved druggability while maintaining potency.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20422267      PMCID: PMC7088613          DOI: 10.1007/s11095-010-0143-5

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  72 in total

1.  Principles of protein-protein recognition.

Authors:  C Chothia; J Janin
Journal:  Nature       Date:  1975-08-28       Impact factor: 49.962

2.  Announcing the worldwide Protein Data Bank.

Authors:  Helen Berman; Kim Henrick; Haruki Nakamura
Journal:  Nat Struct Biol       Date:  2003-12

3.  A comparative study of the relationship between protein structure and beta-aggregation in globular and intrinsically disordered proteins.

Authors:  Rune Linding; Joost Schymkowitz; Frederic Rousseau; Francesca Diella; Luis Serrano
Journal:  J Mol Biol       Date:  2004-09-03       Impact factor: 5.469

4.  The yeast prion Ure2p native-like assemblies are toxic to mammalian cells regardless of their aggregation state.

Authors:  Laura Pieri; Monica Bucciantini; Daniele Nosi; Lucia Formigli; Jimmy Savistchenko; Ronald Melki; Massimo Stefani
Journal:  J Biol Chem       Date:  2006-03-29       Impact factor: 5.157

5.  Spontaneous fibril formation by polyalanines; discontinuous molecular dynamics simulations.

Authors:  Hung D Nguyen; Carol K Hall
Journal:  J Am Chem Soc       Date:  2006-02-15       Impact factor: 15.419

6.  The 3D profile method for identifying fibril-forming segments of proteins.

Authors:  Michael J Thompson; Stuart A Sievers; John Karanicolas; Magdalena I Ivanova; David Baker; David Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-07       Impact factor: 11.205

7.  Identification of amyloid fibril-forming segments based on structure and residue-based statistical potential.

Authors:  Zhuqing Zhang; Hao Chen; Luhua Lai
Journal:  Bioinformatics       Date:  2007-06-28       Impact factor: 6.937

8.  Generic hydrophobic residues are sufficient to promote aggregation of the Alzheimer's Abeta42 peptide.

Authors:  Woojin Kim; Michael H Hecht
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-12       Impact factor: 11.205

Review 9.  Assembly of IgH CDR3: mechanism, regulation, and influence on antibody diversity.

Authors:  L VanDyk; K Meek
Journal:  Int Rev Immunol       Date:  1992       Impact factor: 5.311

10.  Bacterial inclusion bodies contain amyloid-like structure.

Authors:  Lei Wang; Samir K Maji; Michael R Sawaya; David Eisenberg; Roland Riek
Journal:  PLoS Biol       Date:  2008-08-05       Impact factor: 8.029

View more
  22 in total

1.  High throughput detection of antibody self-interaction by bio-layer interferometry.

Authors:  Tingwan Sun; Felicia Reid; Yuqi Liu; Yuan Cao; Patricia Estep; Claire Nauman; Yingda Xu
Journal:  MAbs       Date:  2013-08-19       Impact factor: 5.857

2.  6th Annual European Antibody Congress 2010: November 29-December 1, 2010, Geneva, Switzerland.

Authors:  Alain Beck; Thierry Wurch; Janice M Reichert
Journal:  MAbs       Date:  2011-03-01       Impact factor: 5.857

3.  Coupling of aggregation and immunogenicity in biotherapeutics: T- and B-cell immune epitopes may contain aggregation-prone regions.

Authors:  Sandeep Kumar; Satish K Singh; Xiaoling Wang; Bonita Rup; Davinder Gill
Journal:  Pharm Res       Date:  2011-03-25       Impact factor: 4.200

4.  Rational design of viscosity reducing mutants of a monoclonal antibody: hydrophobic versus electrostatic inter-molecular interactions.

Authors:  Pilarin Nichols; Li Li; Sandeep Kumar; Patrick M Buck; Satish K Singh; Sumit Goswami; Bryan Balthazor; Tami R Conley; David Sek; Martin J Allen
Journal:  MAbs       Date:  2015       Impact factor: 5.857

Review 5.  Structure, heterogeneity and developability assessment of therapeutic antibodies.

Authors:  Yingda Xu; Dongdong Wang; Bruce Mason; Tony Rossomando; Ning Li; Dingjiang Liu; Jason K Cheung; Wei Xu; Smita Raghava; Amit Katiyar; Christine Nowak; Tao Xiang; Diane D Dong; Joanne Sun; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2018-12-17       Impact factor: 5.857

6.  IgG Fab fragments forming bivalent complexes by a conformational mechanism that is reversible by osmolytes.

Authors:  Alfreda D Nelson; Michele M Hoffmann; Christopher A Parks; Surendra Dasari; Adam G Schrum; Diana Gil
Journal:  J Biol Chem       Date:  2012-10-29       Impact factor: 5.157

7.  High-throughput screening for developability during early-stage antibody discovery using self-interaction nanoparticle spectroscopy.

Authors:  Yuqi Liu; Isabelle Caffry; Jiemin Wu; Steven B Geng; Tushar Jain; Tingwan Sun; Felicia Reid; Yuan Cao; Patricia Estep; Yao Yu; Maximiliano Vásquez; Peter M Tessier; Yingda Xu
Journal:  MAbs       Date:  2013-12-06       Impact factor: 5.857

8.  Concentration dependent viscosity of monoclonal antibody solutions: explaining experimental behavior in terms of molecular properties.

Authors:  Li Li; Sandeep Kumar; Patrick M Buck; Christopher Burns; Janelle Lavoie; Satish K Singh; Nicholas W Warne; Pilarin Nichols; Nicholas Luksha; Davin Boardman
Journal:  Pharm Res       Date:  2014-06-07       Impact factor: 4.200

Review 9.  Progress and challenges for the machine learning-based design of fit-for-purpose monoclonal antibodies.

Authors:  Rahmad Akbar; Habib Bashour; Puneet Rawat; Philippe A Robert; Eva Smorodina; Tudor-Stefan Cotet; Karine Flem-Karlsen; Robert Frank; Brij Bhushan Mehta; Mai Ha Vu; Talip Zengin; Jose Gutierrez-Marcos; Fridtjof Lund-Johansen; Jan Terje Andersen; Victor Greiff
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 5.857

10.  Exploring the sequence features determining amyloidosis in human antibody light chains.

Authors:  Puneet Rawat; R Prabakaran; Sandeep Kumar; M Michael Gromiha
Journal:  Sci Rep       Date:  2021-07-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.